Agilent Technologies (A) Total Current Liabilities (2009 - 2026)
Agilent Technologies' (A) quarterly Total Current Liabilities came in at $2.3 billion in Q3 2026, up 20.98% year-over-year from $1.9 billion in Q3 2025, and up 0.88% quarter-over-quarter from $2.3 billion in Q2 2026.
Analysis
Agilent Technologies (A) Total Current Liabilities (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Total Current Liabilities for 18 consecutive years, with $2.3 billion the latest figure, recorded in Q3 2026.
- On a quarterly basis, Total Current Liabilities rose 20.98% year-over-year to $2.3 billion in Q3 2026; TTM through Jul 2026 was $2.3 billion, a 20.98% increase from a year earlier, with the FY2025 full-year figure at $2.3 billion, up 23.85% from the prior year.
- Total Current Liabilities was $2.3 billion for Q3 2026 at Agilent Technologies, up from $2.3 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $2.4 billion in Q3 2024 and troughed at $1.6 billion in Q1 2022.
- A 5-year average of $1.9 billion and a median of $1.9 billion in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities soared 35.74% in 2024 and decreased 20.8% in 2025, its largest moves.
- Over 5 years, Total Current Liabilities stood at $1.9 billion in 2022, then declined by 13.86% to $1.6 billion in 2023, then gained by 18.22% to $1.9 billion in 2024, then gained by 23.85% to $2.3 billion in 2025, then declined by 2.47% to $2.3 billion in 2026.
- The last three Total Current Liabilities figures came in at $2.3 billion (Q3 2026), $2.3 billion (Q2 2026), and $2.2 billion (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 15.07 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 8.11 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 2.29 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 1.58 Bn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 1.28 Bn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 163.70 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 961.30 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 132.66 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 118.51 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 1.20 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 2.29 Bn |
| Apr 30, 2026 | 2.27 Bn |
| Jan 31, 2026 | 2.23 Bn |
| Oct 31, 2025 | 2.35 Bn |
| Jul 31, 2025 | 1.89 Bn |
| Apr 30, 2025 | 2.01 Bn |
| Jan 31, 2025 | 1.87 Bn |
| Oct 31, 2024 | 1.90 Bn |
| Jul 31, 2024 | 2.39 Bn |
| Apr 30, 2024 | 1.96 Bn |
| Jan 31, 2024 | 1.62 Bn |
| Oct 31, 2023 | 1.60 Bn |
| Jul 31, 2023 | 1.76 Bn |
| Apr 30, 2023 | 1.67 Bn |
| Jan 31, 2023 | 1.94 Bn |
| Oct 31, 2022 | 1.86 Bn |
| Jul 31, 2022 | 1.90 Bn |
| Apr 30, 2022 | 1.81 Bn |
| Jan 31, 2022 | 1.58 Bn |
| Oct 31, 2021 | 1.71 Bn |